Emergent Biosolutions Inc (EBS)
SG&A Expense Growth
-4.29%
Quarterly · Period ending:
EBS SG&A Expense Growth
Latest reported-4.29%period ending
Latest reported-4.29%period ending
EBS Quarterly SG&A Growth (QoQ) (0.00% → -4.29%)
Latest values, visible window
High-resolution chart · PNG
EBS sg&a expense growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | SG&A Expense Growth |
|---|---|
| -4.2918% | |
| -8.8063% | |
| 31.701% | |
| -11.8182% | |
| -16.5085% | |
| -13.1796% | |
| -20.0264% | |
| -1.8111% | |
| -8.8443% | |
| -5.1454% | |
| 12.1706% | |
| -12.7054% | |
| -5.1921% | |
| 3.1049% | |
| 14.1809% | |
| 2.8931% | |
| -6.25% | |
| -9.9788% | |
| 14.7381% | |
| -9.9781% | |
| 12.7318% | |
| -1.4616% | |
| 8.7417% | |
| -0.6579% | |
| 9.0387% | |
| -3.4626% | |
| 11.0769% | |
| -8.1921% | |
| 8.2569% | |
| -14.1732% | |
| 80.9976% | |
| 6.5823% | |
| -1.25% | |
| -3.3326% | |
| 19.9287% | |
| 8.2685% | |
| -9.3371% | |
| 19.4725% | |
| -20.3525% | |
| 2.8225% | |
| 13.2816% | |
| -9.0849% | |
| 35.2016% | |
| -1.7891% | |
| -23.1714% | |
| 43.6379% | |
| -21.4149% | |
| -0.8607% | |
| 1.5487% | |
| 66.0449% | |
| -17.463% | |
| 7.0923% | |
| 2.3617% | |
| 2.8343% | |
| 1.6758% | |
| 7.0411% | |
| -8.1931% | |
| 6.7821% | |
| 4.7155% | |
| -14.4819% | |
| 11.9262% | |
| -15.9614% | |
| 4.7262% | |
| 17.2474% | |
| 8.9983% | |
| -13.2773% | |
| -5.5446% | |
| 2.0338% | |
| 21.2707% | |
| 15.2265% | |
| -1.7783% | |
| -6.144% | |
| 24.7015% | |
| -27.6371% | |
| 10.8259% | |
| 18.793% | |
| 13.0975% | |
| -3.9145% | |
| 6.0543% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 14.7381% | |
| -10.1751% | |
| 7.783% | |
| -9.9788% | |
| 0% |